3SOF

I think Tirebldr is right....  I saw a chart of the biotechs and it did look to my untrained eye (well a little trained    ) that the biotechs have bottomed out.

I hope not to step on anybodies toes here as  I am the new guy...  All of us have different time frames and reasons for purchasing a stock.  I have, what I think, is a longer time frame and therefore I have a little more leaway when the price drops. I really don't want a stock to shoot straight up... cause it very well comes straight back down. I am quite happy with a nice slow even advance. A little here a little there. Since I have a longer time frame, I have done my research, and I believe in the company  I am OK with a 15% - 20% drop. If it drops a lot I will research again and check that nothing important has changed with the company. If everythings cool then it must be something technical in the chart or normal volatility... I would be inclined to purchase some more. I think the patient ones here will be rewarded very nicely...

What can be better than a good company in a group that has bottomed out ?

Have a Great Weekend !

Steve

I believe daytraders jumped in at 2 thinking 2.30 was possible but it was too late in the day for it to shake out and regroup..so many exited on lower volume but i believe many are also holding through the weekend. Watch for much higher volume on monday from institutional buyers and Merck investors who check the weekend papers and who stepped out early friday -summer hours. Its going to be a very green week after so much consolidation.

I am holding until the 50 crosses the 200 in a few weeks that will be a big signal to more cautious investors and another big volume increase. I wont make predictions but there is a lot of room for XOMA to move up. May follow VPHM's action

>>I think Tirebldr is right....

Twernt my words friend. I had been watching Yahoo list all day long and simply pillaged a few of their posts thinking they were very pertinent.  I mustn't take credit for being to market-smart yet. Not till I make my first million that is

Have a great weekend yu-uns!!
Art

Jumping in again monday for another 200day hurdle. I like this one, XOMA. Gonna keep it on the radar for a possible daily-daytrade. Thanks everybody!

Should start in green in pre market on Tuesday

Did everyone sell ?

Hey Stravis,

I'm still with it, a significant close under the 9 ema and I'm out, its bouncing support $1.80 - resistance $2.00 and soon one of them will give way. I think $1.80 support is the stronger.
Mike

David Randolph is a very good trader but after I bought XOMA, and XOMA fell, I simply continued to buy as it fell....now I'm in the Black and think XOMA has upside potential to $2.20 in the next week or so.  But even at $2.00 I'd have a nice little profit for a week's trouble...so my question is, why did D.R. sell XOMA at a loss when he liked the fundamentals?  Sometimes, you don't trade out of a lost position, you simply love it lower.  That worked well for me with CYOS when it fell from .03 to .007 (and then I rode it back to .06), and more recently with XIDE, buying as it fell from the low 5s to the high 4s and taking profit yesterday at $5.41...XIDE will be a great in-and-out stock for weeks or months now...nothing like a giant turnaround play....I don't see any reason not to buy even more XOMA if it falls below 1.80....Buy below there and sell above $2.00 is my short term strategy--although it might move quickly above $2.20 in which case I might be tempted to see if there's more to such a rally.  GL 2 1 & All

I'm stil in. Like it or not.

For me it was more a matter of better horses to ride.  Moved my XOMA to GLGS, which is climbing much faster.

Lexicon Collaboration
by: faithinxoma (58/M/NY)
Long-Term Sentiment: Strong Buy    06/21/05 07:58 am
Msg: 115332 of 115346

Lexicon Genetics and XOMA Establish Collaboration for Antibody Drug Development and Commercialization
Tuesday June 21, 7:30 am ET


THE WOODLANDS, Texas; BERKELEY, Calif., June 21 /PRNewswire-FirstCall/ -- Lexicon Genetics Incorporated (Nasdaq: LEXG - News) and XOMA Ltd. (Nasdaq: XOMA - News) announced today the formation of a collaboration to jointly develop and commercialize antibody drugs for certain targets discovered by Lexicon. The collaboration is designed to combine Lexicon's target discovery and biotherapeutics capabilities with XOMA's antibody generation, process development and manufacturing expertise to accelerate the development and commercialization of novel therapeutic antibodies.
ADVERTISEMENT


During the three-year initial term, Lexicon will select for submission to the collaboration targets from among those discovered and analyzed in its Genome5000(TM) program. In this program, Lexicon is using its gene knockout technology to discover the physiological functions of 5,000 potential drug targets. XOMA will generate or engineer antibodies that modulate the collaboration's targets using phage display libraries and its proprietary Human Engineering(TM) technology. Lexicon and XOMA will jointly develop and commercialize novel antibodies directed at these targets and will share the responsibility and costs for research, preclinical, clinical and commercialization activities. Costs and profits will be allocated 65% to Lexicon and 35% to XOMA. XOMA will have principal responsibility for manufacturing antibodies for use in clinical trials and commercial sales.

Lexicon and XOMA have already selected an initial target for inclusion in the collaboration. This target is a secreted protein that, when knocked out, results in leanness, resistance to diet-induced obesity and enhanced insulin sensitivity. Antibodies to this target may have utility in the treatment of type II diabetes, obesity and metabolic diseases. Lexicon has agreed to submit at least two other targets for consideration by the collaboration during the initial term.

"XOMA's broad array of antibody technologies and its strong intellectual property position in this area provide the collaboration a range of options for the development of Lexicon's promising antibody targets," said Arthur T. Sands, M.D., Ph.D., president and chief executive officer of Lexicon. "In addition, XOMA's process development and manufacturing capabilities will enable us to move more rapidly through development and to the commercialization of our future therapeutic products."

"Lexicon's validated antibody targets create a strong foundation for developing new and unique therapeutics based on novel mechanisms of action," said John L. Castello, president, chairman and chief executive officer of XOMA. "Combining these targets with XOMA's antibody expertise should create a formula for successful drug development."

XOMA at 1.75 or 2.20 is an amazing buy...I'm expecting a return to the two year high $10 range by next summer and i will swing it along the way at various levels. I'm in at 1.38 and plan first sale at 3.00 This is the first time i have held any XOMA since 2002-3 when i did very well with it.

Quote from: biobuy on June 21, 2005, 10:28:55 AM
XOMA at 1.75 or 2.20 is an amazing buy...I'm expecting a return to the two year high $10 range by next summer and i will swing it along the way at various levels. I'm in at 1.38 and plan first sale at 3.00 This is the first time i have held any XOMA since 2002-3 when i did very well with it.

A good friend told me his dad, a few years ago, sent his sister through college on XOMA. This is the kind of long range tutorial a guy as myself can learn from.  Thanks for the input.

I also monitor the Yahoo lists, but I find a tremendous amount of hype on there as longs and shorts are trying to hype up everyone to their way of thinking. None of that on 3StocksOnFire. Just good, honest folks helping and learning. I appreciate you folks so much.

art

Quote from: biobuy on June 21, 2005, 10:28:55 AM
XOMA at 1.75 or 2.20 is an amazing buy...I'm expecting a return to the two year high $10 range by next summer and i will swing it along the way at various levels. I'm in at 1.38 and plan first sale at 3.00 This is the first time i have held any XOMA since 2002-3 when i did very well with it.

Could you explain, please, why you decided to get >> in at 1.38 ti $3 ??   TIA!!

Hang in there folks.... these shakes are just that shakes for shares we will bounce very well off this level. everytime the price and the 5 and 10 day average converged shot up after.